VIVUS Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
81,082.00
114,181.00
95,430.00
124,258.00
65,373.00
65,062
Cost of Goods Sold (COGS) incl. D&A
4,868.00
33,387.00
34,157.00
10,602.00
17,187.00
23,253
Gross Income
76,214.00
80,794.00
61,273.00
113,656.00
48,186.00
41,809
SG&A Expense
187,912.00
125,675.00
89,489.00
57,971.00
45,393.00
43,288
EBIT
121,923.00
47,051.00
-
55,685.00
2,793.00
1,479
Unusual Expense
32,456.00
3,660.00
2,539.00
-
-
573
Non Operating Income/Expense
938.00
30.00
490.00
575.00
71.00
970
Interest Expense
19,532.00
32,535.00
33,317.00
32,888.00
33,231.00
33,876
Pretax Income
174,849.00
83,276.00
93,104.00
23,372.00
30,509.00
36,898
Income Tax
97.00
629.00
3.00
70.00
2.00
52
Consolidated Net Income
174,946.00
82,647.00
93,107.00
23,302.00
30,511.00
36,950
Net Income
174,946.00
82,647.00
93,107.00
23,302.00
30,511.00
36,950
Net Income After Extraordinaries
175,436.00
82,647.00
93,107.00
23,302.00
30,511.00
36,950
Net Income Available to Common
174,456.00
82,647.00
93,107.00
23,302.00
30,511.00
36,950
EPS (Basic)
1.72
0.80
0.90
0.22
0.29
3.48
Basic Shares Outstanding
101,174.00
103,456.00
103,926.00
104,385.00
105,741.00
10,621
EPS (Diluted)
1.72
0.80
0.90
0.22
0.29
3.48
Diluted Shares Outstanding
101,174.00
103,456.00
103,926.00
104,969.00
105,741.00
10,621
EBITDA
120,950.00
45,939.00
56,351.00
56,765.00
3,604.00
7,396
Other Operating Expense
10,225.00
2,170.00
29,522.00
-
-
-

About VIVUS

View Profile
Address
900 East Hamilton Avenue
Campbell California 95008
United States
Employees -
Website http://www.vivus.com
Updated 07/08/2019
VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. Its products include Qsymia and STENDRA/SPEDRA. The company was founded by Virgil A.